Bay Area Reporter - July 17, 2008
Bob Roehr
The provision to repeal the travel ban was included in the reauthorization of the President's Emergency Plan for AIDS Relief.
Senators John Kerry (D-Massachusetts) and Gordon Smith (R-Oregon) led the effort to drop U.S. travel and immigration restrictions on persons who are HIV-positive that had been in place for decades. The Foreign Relations Committee agreed to that, but Senator Jeff Sessions (R-Alabama) vowed to reinstate the provisions.
The Congressional Budget Office had said that lifting the restrictions could cost the U.S. an estimated $83 million in additional medical costs over the next 10 years. A compromise increased the visa application fee by $1 and the immigration application fee by $2 to cover anticipated increased medical costs for a variety of illnesses. And Sessions was placated with a substitute amendment.
Gay pundit Andrew Sullivan had been among those pushing for the revision. He was ecstatic with passage. "For those of us who have long dreamed of becoming Americans, and have been prevented by the 1993 law from even being able to enter or leave the U.S. without waivers or fear of humiliation, this is a massive burden lifted."
"I'm not exaggerating when I say that it's one of the happiest days of my whole life ... the lifting of this threat û the sense that I now have a home I know will be secure for me and my husband û is indescribable."
Michael Saag, vice chair of the HIV Medical Association, said, "It is gratifying to know that my HIV-positive colleagues from other countries will finally be allowed to come to the United States to share their expertise."
The Human Rights Campaign played a leading role in lobbying repeal of the travel ban.
"We applaud the Senate for rejecting this unjust and sweeping policy that deems HIV-positive individuals inadmissible to the United States," said Joe Solmonese, HRC president.
"Congress has finally moved to end the HIV ban û a ban based on myth and misinformation," said Rachel B. Tiven, executive director of Immigration Equality. "For 20 years, the United States has barred HIV-positive travelers from entering the country even for one day. Today the Senate said loud and clear that AIDS exceptionalism must come to an end."
The ban originated in 1987, and explicitly codified by Congress in 1993, despite efforts in the public health community to remove the ban when Congress reformed U.S. immigration law in the early 1990s. While immigration law currently excludes foreigners with any "communicable disease of public health significance" from entering the U.S., only HIV is explicitly named in the statute. For all other illnesses, the secretary of Health and Human Services retains the ability, with the medical expertise of his department, to determine which illnesses truly pose a risk to public health.
PEPFAR
PEPFAR, the U.S. international AIDS effort, was also renewed for another five years.
Conservatives in the Senate used legislative tactics to try to scale back spending and re-impose greater ideological constrictions on how the money might be spent. Some of those restrictions had been eased during reauthorization. Minor accommodations were made to the conservatives but they largely failed in a series of votes over July 15-16.
The PEPFAR budget will more than triple to $50 billion over the life of the program. Another major provision is lifting travel and immigration restrictions on persons who are HIV-positive. HIV will now be treated like every other infectious disease.
The procedural logjam began to break up on July 11 when the Senate voted 65-3 to close debate and vote on PEPFAR the following week. Conservative opponent Jim DeMint (R-South Carolina) had angered colleagues by demanding the recorded vote late on a Friday afternoon, and then didn't even bother to stick around to vote.
The key first vote on July 15 was on an amendment by DeMint that sought to limit PEPFAR to the 15 low-income countries that are the focus of current operations. The Senate tabled it by a vote of 70-24. All Democrats supported the motion and were joined by about half the Republicans. Senators Barack Obama and John McCain did not vote.
An amendment by Senator Jim Bunning (R-Kentucky) would have limited spending to $15 billion, the same amount as the current program. It was resoundingly defeated, 16-80. Another amendment, to reduce overall spending to $35 billion, went down 31-64. The final bill passed the Senate 80-16.
The legislation carries the names of Henry Hyde and Tom Lantos, the late Republican and Democratic leaders in the House who had championed a bipartisan U.S. international AIDS effort. Perhaps the most minor but also the most offensive amendment was to add the name of the recently deceased Jesse Helms to the legislation, offered by Senator Elizabeth Dole (R-North Carolina).
Helms had been the most intransient opponent of funding for AIDS programs, foreign and domestic. AIDS activists were livid at Dole's suggestion, which was introduced but not considered.
It is expected that that the House will accept the minor changes by the Senate. President Bush has pushed for the legislation, which is likely to be one of the few positive legacies of his tenure in the White House.
080717
BR080707
Copyright © 2008 - The Bay Area Reporter. Reproduction of this article (other than one copy for personal reference) must be cleared through the The Bay Area Reporter.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .